By Stephen Nakrosis
Shockwave Medical, Inc. said Friday the Centers for Medicare & Medicaid Services approved a transitional pass-through payment for the Shockwave C(2) Coronary IVL device.
The company said the approval, which is effective July 1, "provides incremental payment for Shockwave C(2) devices used in the hospital outpatient settings." It also said the device will be eligible for TPT payments for three years.
The CMS said as part of the payment calculation, a "customary deduction known as a device offset will not be applied to coronary stenting procedures involving coronary IVL" according to Shockwave.
Write to Stephen Nakrosis at [email protected]